BioSpace News Archive

Myriad Genetics Highlights 2022 Research Findings that Help Advance More Accessible and Equitable Genetic Testing

Myriad Genetics, Inc. , (NASDAQ: MYGN), a leader in genetic testing and precision medicine, highlighted impactful clinical studies from 2022 that underscore the company’s commitment to making genetic testing more accessible and equitable for all patient populations.

February 7, 2023

·

5 min read

Business

Incyte Reports 2022 Fourth Quarter and Year-end Financial Results, Provides 2023 Financial Guidance and Updates on Key Clinical Programs

Incyte Reports 2022 Fourth Quarter and Year-end Financial Results, Provides 2023 Financial Guidance and Updates on Key Clinical Programs.

February 7, 2023

·

31 min read

Business

Corentec Appoints Michael Son as Executive Vice President

Corentec, a forward-thinking medical device company focused on developing solutions for the orthopedic market, has re-hired Michael Son to lead its sales and business development operations in the Americas.

February 7, 2023

·

2 min read

Business

Syneos Health and Haystack Health Partner to Accelerate Clinical Trials with AICombined Capabilities Will Help Improve Trial Lifecycles for Patients, Sites & Sponsors

Syneos Health® announced a strategic partnership with Haystack Health, a Roivant Health portfolio company developing advanced Artificial Intelligence and Natural Language Processing solutions, to improve the identification and enrollment of patients for clinical trials.

February 7, 2023

·

4 min read

Biotech Bay

Harpoon Therapeutics to Participate in the SVB Securities Global Biopharma Conference

Harpoon Therapeutics, Inc. today announced that management will present at the virtual SVB Securities Global Biopharma Conference.

February 7, 2023

·

1 min read

Business

Quipt Home Medical Announces Date and Time for Fiscal Q1 2023 Conference Call and Audio Webcast

Quipt Home Medical Corp. today announced that it will host its Fiscal Q1 2023 earnings conference call and audio webcast on Tuesday, February 14, 2023 at 10:00 a.m. (EST).

February 7, 2023

·

1 min read

Business

ELEVAI LABS EXPANDS BOARD OF DIRECTORS WITH THE APPOINTMENT OF GLOBAL AESTHETICS EXECUTIVE CRYSTAL MUILENBURG

ELEVAI LABS, INC ., a medical aesthetic biotechnology company specializing in physician-dispensed skincare, proudly announces the addition of Crystal Muilenburg as an independent member of the company’s Board of Directors.

February 7, 2023

·

2 min read

Drug Development

Neuron23 Announces First-in-Human Dose in Phase 1 Clinical Trial of its Best-in-Class Brain-Penetrant LRRK2 Inhibitor for Parkinson’s Disease

Neuron23™ Inc. today announced that the Company recently initiated dosing in a Phase 1 clinical trial of NEU-723 for the treatment of Parkinson’s disease.

February 7, 2023

·

4 min read

Biotech Beach

LevitasBio Launches LeviSelect Suite of Cell Depletion & Enrichment Kits

LevitasBio, Inc., a premier end-to-end sample processing and cellular analysis provider to the life sciences market, unveils a suite of LeviSelect™ cell depletion and enrichment kits for immunology research.

February 7, 2023

·

3 min read

Genetown

Selecta Biosciences to Participate at the SVB Securities Global Biopharma Conference

Selecta Biosciences, Inc. today announced that Company’s Management will provide a corporate update and participate in one-on-one investor meetings at the SVB Securities Global Biopharma Conference, to be held virtually from February 14-16, 2023.

February 7, 2023

·

1 min read